SIPPET Study
The recently published SIPPET study which looked at the relative risk of developing inhibitors using recombinant FVIII as opposed to plasma-derived FVIII containing von Willebrand factor demonstrated a significantly higher …
Uncategorised
I.H.S. Hoodies
Our comfy I.H.S. hoodies are now available to purchase at all of our events and conferences. They come in a range of different sizes and are priced from €20 to …
EHC Leadership Conference 2016
The second standalone EHC leadership conference took place in Brussels from the 9th to the 12th of June, 2016. The conference brought together volunteers, staff and board members from each …
New therapeutic developments in haemophilia
Extended Half-Life Factor VIII In November 2015, the first extended half-life (EHL) factor VIII concentrate was licenced in Europe by the European Medicines Agency (EMA). In April 2016, the first …
New Children\’s Hospital
Planning Permission has been granted for the new children’s hospital in St. James’s Hospital. The Irish Haemophilia Society are delighted that planning permission has been granted, for the new children’s hospital …
Travel Insurance
When you are travelling abroad Travel Insurance is vital. Medical insurance should be checked well in advance of departure as it can be difficult to obtain for a person with …
vCJD update
The first case of variant Creutzfeldt-Jakob disease (vCJD) in a patient that is genetically different from all previous confirmed cases, has been reported in the UK. This suggests, as researchers …
Parents Conference
The Parents Conference 2016 will take place on 24th – 26th June in the Sheraton Hotel, Athlone, Co. Westmeath. As this is one of our biggest conference, we would ask …
National Ambulance Service
We are pleased to announce, with immediate effect, through the work of the National Haemophilia Council (NHC), the National Ambulance Service (NAS), the Health Service Executive (HSE) and the Irish …